Philip Zachariah to Child
This is a "connection" page, showing publications Philip Zachariah has written about Child.
Connection Strength
0.277
-
Household level SARS-CoV-2 sero-epidemiology in a high prevalence group of adults and children-implications for community infection control. Am J Infect Control. 2021 11; 49(11):1438-1440.
Score: 0.029
-
Severity predictors in pediatric SARS-CoV-2 and MIS-C. J Pediatr. 2021 05; 232:307-310.
Score: 0.028
-
Symptomatic Infants Have Higher Nasopharyngeal SARS-CoV-2 Viral Loads but Less Severe Disease Than Older Children. Clin Infect Dis. 2020 11 19; 71(16):2305-2306.
Score: 0.027
-
Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children's Hospital in New York City, New York. JAMA Pediatr. 2020 10 01; 174(10):e202430.
Score: 0.027
-
Biphasic Variation Over Time in Presenting Features of Patients With COVID-19. Pediatrics. 2020 11; 146(5).
Score: 0.027
-
Culture-Independent Analysis of Pediatric Bronchoalveolar Lavage Specimens. Ann Am Thorac Soc. 2018 09; 15(9):1047-1056.
Score: 0.023
-
Antibiotic Use in Hospitalized Children With Respiratory Viruses Detected by Multiplex Polymerase Chain Reaction. Pediatr Infect Dis J. 2018 05; 37(5):443-446.
Score: 0.023
-
Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children. Pediatrics. 2021 08; 148(2).
Score: 0.007
-
Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19. Ann Intern Med. 2021 08; 174(8):1151-1158.
Score: 0.007
-
Initial Guidance on Use of Monoclonal Antibody Therapy for Treatment of Coronavirus Disease 2019 in Children and Adolescents. J Pediatric Infect Dis Soc. 2021 May 28; 10(5):629-634.
Score: 0.007
-
Multisystem Inflammatory Syndrome in Children Associated With Coronavirus Disease 2019 in a Children's Hospital in New York City: Patient Characteristics and an Institutional Protocol for Evaluation, Management, and Follow-Up. Pediatr Crit Care Med. 2021 03 01; 22(3):e178-e191.
Score: 0.007
-
Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2. J Pediatric Infect Dis Soc. 2021 Feb 13; 10(1):34-48.
Score: 0.007
-
Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2. J Pediatric Infect Dis Soc. 2020 Dec 31; 9(6):701-715.
Score: 0.007
-
Acute Hepatitis Is a Prominent Presentation of the Multisystem Inflammatory Syndrome in Children: A Single-Center Report. Hepatology. 2020 11; 72(5):1522-1527.
Score: 0.007
-
Discriminating Multisystem Inflammatory Syndrome in Children Requiring Treatment from Common Febrile Conditions in Outpatient Settings. J Pediatr. 2021 Feb; 229:26-32.e2.
Score: 0.007
-
A Clinical Pathway for Hospitalized Pediatric Patients With Initial SARS-CoV-2 Infection. Hosp Pediatr. 2020 09; 10(9):810-819.
Score: 0.007
-
Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City. JAMA. 2020 Jul 21; 324(3):294-296.
Score: 0.007
-
Gastrointestinal Symptoms as a Major Presentation Component of a Novel Multisystem Inflammatory Syndrome in Children That Is Related to Coronavirus Disease 2019: A Single Center Experience of 44 Cases. Gastroenterology. 2020 Oct; 159(4):1571-1574.e2.
Score: 0.007
-
Seasonality and clinical impact of human parainfluenza viruses. Influenza Other Respir Viruses. 2018 11; 12(6):706-716.
Score: 0.006
-
Epidemiology and Clinical Features of Human Coronaviruses in the Pediatric Population. J Pediatric Infect Dis Soc. 2018 May 15; 7(2):151-158.
Score: 0.006
-
A multi-institutional analysis of children on long-term non-invasive respiratory support and their outcomes. Pediatr Pulmonol. 2018 04; 53(4):498-504.
Score: 0.006